Members Directory

Ipsen Bioscience, Inc.

x

Activity area : Biotechnology

Website : www.ipsenus.com

650 East Kendall Street

Massachusetts

02142

Cambridge

Etats-Unis d'Amérique

About Ipsen

Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its fields of expertise cover oncology, neurosciences and endocrinology. Ipsen’s commitment to oncology is exemplified through its growing portfolio of key therapies improving the care of patients suffering from prostate cancer, bladder cancer and neuro-endocrine tumors. Ipsen also has a significant presence in primary care. Moreover, the Group has an active policy of

partnerships. Ipsen's R&D is focused on its innovative and differentiated technological platforms, peptides and toxins, located in the heart of the leading biotechnological and life sciences hubs (Les Ulis/Paris-Saclay, France; Slough/Oxford, UK; Cambridge, US). In 2015, R&D expenditure totaled close to €193 million. The Group has more than 4,600 employees worldwide. Ipsen’s shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the “Service de Règlement Différé” (“SRD”). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the

over-the-counter market in the United States under the symbol IPSEY. For more information on Ipsen, visit www.ipsen.com.

For more information or consult the global directory, become a member or login to the private area of our website.

Upcoming events

Calendar of events

< December 2017 >
Mon.Tue.Wed.Thu.Fri.Sat.Sun.
1
2
3
4
5
6 7
8
9
10
11
12
13
14 15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

They Support FACCNE

    • AEC Partners
    • Alira Health
    • Aquto
    • Axelia Partners (former Marie Landel & Associates)
    • Bewell Connect
    • BioMerieux
    • Boston Accueil
    • Boston Green
    • Boston Strasbourg Sister City Association
    • CM CIC
    • Cisbio
    • DSML Executive Search
    • Dassault Systems
    • Edenred
    • Essilor
    • French Cultural Center
    • French Tech Hub
    • Good Leads
    • Hubbard
    • Infotraffic system tv
    • Jabra
    • Keolis CS
    • LAZ Parking
    • MGB US Inc.
    • MIRAKL
    • Magicforest
    • Mauna Kea Technologies
    • Mc Dermott Will & Emery
    • Merieux Developpement
    • Miltons Distributing
    • Moderna Therapeutics
    • Munksjo paper
    • NFI
    • Nanobiotix
    • Pact and Partners
    • Paul Frank + Collins P.C.
    • Puma
    • SES America
    • Sanofi Genzyme
    • Schneider Electric
    • Sigfox
    • Socomec
    • Softbank Robotics
    • Spring Technologies
    • Stratx
    • Sullivan & Worcester
    • Valti
    • Veolia
    • Withings
    • World Boston

185 Alewife Brook Parkway, Suite 200 
Cambridge, MA 02138
 T: (617) 520-2121 
 contact(at)faccne.org

Please contact us to schedule an appointment.

 

 

© 2017 FACC NEW ENGLAND